Gemfibrozil
- Product NDC
- 70934-466
- 11-digit product format
- 709340466
- Labeler code
- 70934
- Product ID
- 70934-466_a7aca074-ff60-59aa-e053-2a95a90aef61
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gemfibrozil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA203266
- Marketing category
- ANDA
- Marketing start
- 2019-11-26
- Marketing end
- 0000-00-00
- Substance
- GEMFIBROZIL
- Active strength
- 600 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-466-30 | 70934046630 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-466-30) | 30 tablet | 2020-03-26 | 0000-00-00 | No | No | Current |
| 70934-466-60 | 70934046660 | 60 TABLET in 1 BOTTLE, PLASTIC (70934-466-60) | 60 tablet | 2020-05-19 | 0000-00-00 | No | No | Current |
| 70934-466-90 | 70934046690 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-466-90) | 90 tablet | 2019-11-26 | 0000-00-00 | No | No | Current |